Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004

International Journal of Cardiology

Volumn 135, Issue 2, 2009, Pages 156-161

  Cheung, Bernard M Y ^a   Ong, Kwok Leung ^a   Wong, Louisa Y F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alkaline phosphatase; NHANES; Peripheral arterial disease

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CADMIUM; LEAD; URIC ACID;

ADULT; AGE; AGED; ALCOHOL ABSTINENCE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SMOKING; UNITED STATES; URIC ACID BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; ALCOHOL DRINKING; ALKALINE PHOSPHATASE; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 67349112786     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.039     Document Type: Article

References (36)

1. Sumner AD, Eid S, Parks A, Edris B, Reed III JF. Increasing prevalence of peripheral artery disease in the United States: results from the National Health and Nutrition Examination Survey (1999-2004). Circulation 2007; 116:II-780 (Abstract).
2. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344 (2001) 1608-1621
3. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
4. Wildman R.P., Muntner P., Chen J., Sutton-Tyrrell K., and He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol 96 (2005) 1579-1583
5. Vu J.D., Vu J.B., Pio J.R., et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 96 (2005) 655-658
6. Lane J.S., Vittinghoff E., Lane K.T., Hiramoto J.S., and Messina L.M. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg 44 (2006) 319-324
7. Menke A., Muntner P., Wildman R.P., Dreisbach A.W., and Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 98 (2006) 1226-1230
8. Nasir K., Guallar E., Navas-Acien A., Criqui M.H., and Lima J.A. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 25 (2005) 1966-1971
9. Shankar A., Klein B.E., Nieto F.J., and Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 196 (2008) 749-755
10. Navas-Acien A., Selvin E., Sharrett A.R., Calderon-Aranda E., Silbergeld E., and Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109 (2004) 3196-3201
11. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., and Haffner S.M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54 (2005) 3140-3147
12. Targher G., and Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191 (2007) 235-240
13. Fahrleitner-Pammer A., Obernosterer A., Pilger E., et al. Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int 16 (2005) 319-324
14. Fahrleitner A., Dobnig H., Obernosterer A., et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med 17 (2002) 663-669
15. Kerner A., Avizohar O., Sella R., et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 193-197
16. National Health and Nutrition Examination Survey questionnaire, examination protocol and laboratory protocol. Hyattsville, Maryland: United States Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2000, 2001-2002 and 2003-2004. Available at: http://www.cdc.gov/nchs/data/nhanes. Accessed August 29, 2007.
17. Newman A.B., Siscovick D.S., Manolio T.A., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study: Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
18. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
19. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., and Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007) 69-75
20. Corathers S.D. Focus on diagnosis: the alkaline phosphatase level: nuances of a familiar test. Pediatr Rev 27 (2006) 382-384
21. Pennisi P., Signorelli S.S., Riccobene S., et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15 (2004) 389-395
22. Mangiafico R.A., Russo E., Riccobene S., et al. Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab 24 (2006) 125-131
23. Kaplow L.S. Leukocyte alkaline phosphatase cytochemistry: applications and methods. Ann NY Acad Sci 155 (1968) 911-947
24. Maldonado O., Demasi R., Maldonado Y., Taylor M., Troncale F., and Vender R. Extremely high levels of alkaline phosphatase in hospitalized patients. J Clin Gastroenterol 27 (1998) 342-345
25. Cheung B.M., Ong K.L., Cheung R.V., et al. Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clin Chem Lab Med 46 (2008) 523-527
26. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
27. Tang F.T., Chen S.R., Wu X.Q., et al. Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress. Calcif Tissue Int 79 (2006) 326-339
28. Kim B.J., Yu Y.M., Kim E.N., Chung Y.E., Koh J.M., and Kim G.S. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67 (2007) 152-158
29. Ali A.T., Paiker J.E., and Crowther N.J. The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver-enzymes, albumin, and bilirubin. Am J Clin Pathol 126 (2006) 437-442
30. Ali A.T., Penny C.B., Paiker J.E., et al. Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1. Clin Chim Acta 354 (2005) 101-109
31. Ali A.T., Penny C.B., Paiker J.E., Psaras G., Ikram F., and Crowther N.J. The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue. Ann Clin Biochem 43 (2006) 207-213
32. Lopez-Bermejo A., Botas P., Funahashi T., et al. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf) 60 (2004) 256-263
33. Daimon M., Oizumi T., Saitoh T., et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 26 (2003) 2015-2020
34. Chow W.S., Cheung B.M., Tso A.W., et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49 (2007) 1455-1461
35. Gordon T. Factors associated with serum alkaline phosphatase level. Arch Pathol Lab Med 117 (1993) 187-190
36. Gullihorn L., Karpman R., and Lippiello L. Differential effects of nicotine and smoke condensate on bone cell metabolic activity. J Orthop Trauma 19 (2005) 17-22